Clinical trial
GLUT1: A Novel Tool Reflecting Proliferative Activity of Lung Neuroendocrine Tumors
NCT03645915 is registered in ClinicalTrials.gov with Centre Hospitalier Universitaire, Amiens as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- GLUT1: A Novel Tool Reflecting Proliferative Activity of Lung Neuroendocrine Tumors
- Lead sponsor
- Centre Hospitalier Universitaire, Amiens
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2014
- Completion date
- November 13, 2016
- Enrollment
- 36 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lung tumor